The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Lappe Mark

Reporting owner CIK 0001366074 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Lappe MarkLappe MarkLappe Mark · October 14, 2026 · Purchase · Common StockLappe Mark · October 14, 2026 · Purchase · Common StockLappe Mark · October 14, 2026 · Purchase · Common StockLappe Mark · October 14, 2026 · Purchase · Common StockLappe Mark · October 14, 2026 · Purchase · Common StockLappe Mark · October 14, 2026 · Purchase · Common StockOct 14, 2026Oct 14, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 14, 2026Inhibrx Biosciences, Inc.Common StockLappe MarkPurchase
Oct 14, 2026Inhibrx Biosciences, Inc.Common StockLappe MarkPurchase
Oct 14, 2026Inhibrx Biosciences, Inc.Common StockLappe MarkPurchase
Oct 14, 2026Inhibrx Biosciences, Inc.Common StockLappe MarkPurchase
Oct 14, 2026Inhibrx Biosciences, Inc.Common StockLappe MarkPurchase
Oct 14, 2026Inhibrx Biosciences, Inc.Common StockLappe MarkPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Inhibrx Biosciences, Inc.INBX · company listings
Lappe MarkChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P10085.76Value: 8,576Currency not specifiedView ↗
Trade: Inhibrx Biosciences, Inc.INBX · company listings
Lappe MarkChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P2,45184.9992 *Value: 208,333.0392Currency not specifiedView ↗
Trade: Inhibrx Biosciences, Inc.INBX · company listings
Lappe MarkChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P2,44984.0707 *Value: 205,889.1443Currency not specifiedView ↗
Trade: Inhibrx Biosciences, Inc.INBX · company listings
Lappe MarkChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P10085.76Value: 8,576Currency not specifiedView ↗
Trade: Inhibrx Biosciences, Inc.INBX · company listings
Lappe MarkChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P2,47084.9992 *Value: 209,948.024Currency not specifiedView ↗
Trade: Inhibrx Biosciences, Inc.INBX · company listings
Lappe MarkChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P2,47084.0707 *Value: 207,654.629Currency not specifiedView ↗